sözaltı news Finance
Finance
EN AZ
Teva’s (TEVA) $125 Million BioXcel Bid Offers Upside, but FDA and Auction Risks Remain

Teva’s (TEVA) $125 Million BioXcel Bid Offers Upside, but FDA and Auction Risks Remain

finance.yahoo.com 12.09.2026 18:57 1 views